Kodiak Sciences Inc. (BMV:KOD)

Mexico flag Mexico · Delayed Price · Currency is MXN
428.00
+28.00 (7.00%)
At close: Dec 4, 2025
187.25%
Market Cap22.75B
Revenue (ttm)n/a
Net Income (ttm)-3.99B
Shares Outn/a
EPS (ttm)-75.56
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6
Average Volume535
Open428.00
Previous Close400.00
Day's Range428.00 - 428.00
52-Week Range51.00 - 428.00
Betan/a
RSIn/a
Earnings DateMar 26, 2026

About Kodiak Sciences

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic mac... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2009
Employees 109
Stock Exchange Mexican Stock Exchange
Ticker Symbol KOD
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.